RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM
Perspective Therapeutics Inc (CATX) PT Raised to $16 at RBC Capital Jun 3, 2025 05:05AM
Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results May 12, 2025 04:36PM
Perspective Therapeutics Inc (CATX) PT Lowered to $15 at RBC Capital Mar 27, 2025 11:01AM
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results Mar 26, 2025 04:10PM


Nov 25, 2024 06:23AM Perspective Therapeutics Inc (CATX) PT Lowered to $16 at RBC Capital
Nov 12, 2024 04:05PM Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Aug 16, 2024 06:26AM Perspective Therapeutics Inc (CATX) PT Lowered to $27 at RBC Capital
Jun 14, 2024 06:20AM RBC Capital Reiterates Outperform Rating on Perspective Therapeutics Inc (CATX)
May 24, 2024 08:02AM Perspective Therapeutics (CATX) Prices 51.52M Share Offering at $1.51/sh
May 24, 2024 08:01AM Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 14, 2024 05:54AM RBC Capital Starts Perspective Therapeutics Inc (CATX) at Outperform